133 related articles for article (PubMed ID: 32213653)
1. GnRH antagonist alters the migration of endometrial epithelial cells by reducing CKB.
Chen Q; Fan Y; Zhou X; Yan Z; Kuang Y; Zhang A; Xu C
Reproduction; 2020 May; 159(6):733-743. PubMed ID: 32213653
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of S100P induces apoptosis in endometrial epithelial cell during GnRH antagonist protocol.
Zhang D; Han M; Zhou M; Liu M; Li Y; Xu B; Zhang A
Reprod Biol Endocrinol; 2021 Jul; 19(1):99. PubMed ID: 34215278
[TBL] [Abstract][Full Text] [Related]
3. Increased AIF-1-mediated TNF-α expression during implantation phase in IVF cycles with GnRH antagonist protocol.
Xu B; Zhou M; Wang J; Zhang D; Guo F; Si C; Leung PCK; Zhang A
Hum Reprod; 2018 Jul; 33(7):1270-1280. PubMed ID: 29897458
[TBL] [Abstract][Full Text] [Related]
4. GnRH antagonist weakens endometrial stromal cells growth ability by decreasing c-kit receptor expression.
Xu DF; Liu PP; Fan L; Xie Q; Zhang ZQ; Wang LQ; Wu QF; Tan J
Reprod Biol Endocrinol; 2022 Feb; 20(1):29. PubMed ID: 35120552
[TBL] [Abstract][Full Text] [Related]
5. Comparative proteomics reveal negative effects of gonadotropin-releasing hormone agonist and antagonist on human endometrium.
Chen Q; Yu F; Li Y; Zhang AJ; Zhu XB
Drug Des Devel Ther; 2019; 13():1855-1863. PubMed ID: 31239640
[No Abstract] [Full Text] [Related]
6. Controlled ovarian hyperstimulation for in vitro fertilization alters endometrial receptivity in humans: protocol effects.
Haouzi D; Assou S; Dechanet C; Anahory T; Dechaud H; De Vos J; Hamamah S
Biol Reprod; 2010 Apr; 82(4):679-86. PubMed ID: 20042535
[TBL] [Abstract][Full Text] [Related]
7. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.
Humaidan P; Van Vaerenbergh I; Bourgain C; Alsbjerg B; Blockeel C; Schuit F; Van Lommel L; Devroey P; Fatemi H
Hum Reprod; 2012 Nov; 27(11):3259-72. PubMed ID: 22930004
[TBL] [Abstract][Full Text] [Related]
8. Effects of GnRH antagonist on endometrial protein profiles in the window of implantation.
Meng Y; Guo Y; Qian Y; Guo X; Gao L; Sha J; Cui Y; Chian RC; Liu J
Proteomics; 2014 Oct; 14(20):2350-9. PubMed ID: 25065715
[TBL] [Abstract][Full Text] [Related]
9. GnRH antagonists may affect endometrial receptivity.
Rackow BW; Kliman HJ; Taylor HS
Fertil Steril; 2008 May; 89(5):1234-1239. PubMed ID: 18410932
[TBL] [Abstract][Full Text] [Related]
10. HOXA10 protein expression in the endometrium of normally menstruating women after receiving GnRH antagonist.
Sirayapiwat P; Triratanachat S; Tantbirojn P; Ruangvejvorachai P; Suwajanakorn S
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):321-5. PubMed ID: 23541416
[TBL] [Abstract][Full Text] [Related]
11. Endometrial HOXA10 expression after controlled ovarian hyperstimulation with recombinant follicle-stimulating hormone.
Taylor HS; Daftary GS; Selam B
Fertil Steril; 2003 Sep; 80 Suppl 2():839-43. PubMed ID: 14505762
[TBL] [Abstract][Full Text] [Related]
12. GnRH antagonists and endometrial receptivity in oocyte recipients: a prospective randomized trial.
Prapas N; Tavaniotou A; Panagiotidis Y; Prapa S; Kasapi E; Goudakou M; Papatheodorou A; Prapas Y
Reprod Biomed Online; 2009 Feb; 18(2):276-81. PubMed ID: 19192350
[TBL] [Abstract][Full Text] [Related]
13. [Effect of gonadotropin-releasing hormone-I agonist and gonadotropin-releasing hormone-II on endometrial carcinoma cell lines with different states of PTEN].
Zhao LJ; Wei LH; Li XP; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):45-9. PubMed ID: 19563062
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone type II (GnRH-II) agonist regulates the motility of human decidual endometrial stromal cells: possible effect on embryo implantation and pregnancy.
Wu HM; Huang HY; Lee CL; Soong YK; Leung PC; Wang HS
Biol Reprod; 2015 Apr; 92(4):98. PubMed ID: 25761596
[TBL] [Abstract][Full Text] [Related]
16. Regulation of AMH and SCF expression in human granulosa cells by GnRH agonist and antagonist.
Dong M; Huang L; Wang W; Du M; He Z; Mo Y; Yang D
Pharmazie; 2011 Jun; 66(6):436-9. PubMed ID: 21699083
[TBL] [Abstract][Full Text] [Related]
17. The risk of ectopic pregnancy following GnRH agonist triggering compared with hCG triggering in GnRH antagonist IVF cycles.
Sahin S; Ozay A; Ergin E; Turkgeldi L; Kürüm E; Ozornek H
Arch Gynecol Obstet; 2015 Jan; 291(1):185-91. PubMed ID: 25078054
[TBL] [Abstract][Full Text] [Related]
18. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity.
Orvieto R; Meltzer S; Rabinson J; Zohav E; Anteby EY; Nahum R
Fertil Steril; 2008 Oct; 90(4):1294-6. PubMed ID: 18178197
[TBL] [Abstract][Full Text] [Related]
19. Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles.
Simon C; Oberyé J; Bellver J; Vidal C; Bosch E; Horcajadas JA; Murphy C; Adams S; Riesewijk A; Mannaerts B; Pellicer A
Hum Reprod; 2005 Dec; 20(12):3318-27. PubMed ID: 16085660
[TBL] [Abstract][Full Text] [Related]
20. GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial.
Fusi FM; Brigante CM; Zanga L; Mignini Renzini M; Bosisio C; Fadini R
Reprod Biol Endocrinol; 2019 Nov; 17(1):103. PubMed ID: 31783862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
